Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
- Status
- COMPLETED
- Phase
- PHASE4
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
- Status
- UNKNOWN
- Phase
- PHASE4
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
- Status
- COMPLETED
- Phase
- PHASE3
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML
- Status
- TERMINATED
- Phase
- PHASE1
Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
EDOCH Alternating With DHAP for New Diagnosed Younger MCL
- Status
- COMPLETED
- Phase
- PHASE4
Optimal Treatment Strategy Based on for Pediatric AML
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2